Abstract:A facile hydrothermal strategy is employed to construct a core‐shell heterostructure sonosensitizer comprising metalloporphyrin (Fe‐TCPP) metal organic frameworks (MOFs) and bright DSNPs (NaErF4:Yb@NaLuF4). The coordination of Fe3+ into the macrocycle of TCPP at the MOFs shell is confirmed resulting in a marked decrease in TCPP phosphorescence and a significant increase in singlet oxygen generation, and the subsequent reduction of Fe3+ by GSH facilitates the restoration of DSNPs at 1525 nm, thereby significantly augmenting the generation of reactive oxygen species and enabling real‐time monitoring of sonodynamic therapy. Noninvasive sonodynamic therapy (SDT) shows promise for brain glioma treatment due to deep tissue‐penetrating capabilities (>10 cm) of ultrasound and high spatial resolutions. Yet, this technique is hindered by inefficient production of reactive oxygen species (ROS), resulting from the hypoxic tumor microenvironment (TME), high level of ROS scavenger glutathione (GSH), and the inability to visualize glioma in vivo for precise treatment management and monitoring in current sonosentizers. To address these challenges, we fabricated a core‐shell heterostructure sonosensitizer (labeled as DFM), in which meso‐tetra (4‐carboxyphenyl) porphine (TCPP) porphyrin metal‐organic frameworks (MOF, PCN‐224(Fe)) serve as a porous shell to contain approved chemotherapeutics sorafenib (SRF) to effectively inhibit GSH synthesis, while NaErF4:Yb@NaLuF4 nanoparticles as the core provide TME‐responsive NIR IIb (≈1500–1800 nm) luminescence at 1525 for precise optical imaging. Coordination of Fe3+ into the macrocycle of TCPP at the MOFs shell is found to, besides triggering ferroptosis, reduce TCPP phosphorescence (23% decrease) and increase the triplet state (T1) oxygen quenching, substantially promoting the singlet oxygen generation (2.6‐fold increase). Furthermore, GSH in TME facilitates the reduction of Fe3+ to Fe2+, thereby eliminating the luminescence quenching of Fe3+ and augmenting the NIR IIb luminescence of Er3+ (5‐fold increase) for nanoagents accumulation imaging in intracranial glioma, realizing dynamical monitoring of SDT processes. Compared to control groups, in vitro and in vivo experiments confirm the effective ROS generation and results in a 6‐fold volume reduction of brain gliomas, reaching a survival rate of 80% at 30 days posttreatment.

Porphyrin-based-MOF nanocomposite hydrogels for synergistic sonodynamic and gas therapy against tumor

Erythrocyte Membrane-Camouflaged PCN-224 Nanocarriers Integrated with Platinum Nanoparticles and Glucose Oxidase for Enhanced Tumor Sonodynamic Therapy and Synergistic Starvation Therapy.

Metalloporphyrin MOFs‐Based Nanoagent Enabling Tumor Microenvironment Responsive Sonodynamic Therapy of Intracranial Glioma Signaled by NIR‐IIb Luminescence Imaging

Synergistic therapy for orthotopic gliomas via biomimetic nanosonosensitizer-mediated sonodynamic therapy and ferroptosis

Self‐Assembled Aza‐Boron‐Dipyrromethene‐Based H2S Prodrug for Synergistic Ferroptosis‐Enabled Gas and Sonodynamic Tumor Therapies

Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors

Piezoelectric-mediated two-dimensional copper-based metal-organic framework for synergistic sonodynamic and cuproptosis-driven tumor therapy

All-in-One HN@Cu-MOF nanoparticle with Enhanced Reactive Oxygen Species Generation and GSH Depletion for Effective Tumor Treatment

Metal–organic frameworks as candidates for tumor sonodynamic therapy: Designable structures for targeted multifunctional transformation

MnO2 Decorated Metal‐Organic Framework‐Based Hydrogel Relieving Tumor Hypoxia for Enhanced Photodynamic Therapy

Self-healable oxide sodium alginate/carboxymethyl chitosan nanocomposite hydrogel loading Cu2+-doped MOF for enhanced synergistic and precise cancer therapy

Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression

Multifunctional Oxygen-Generating Nanoflowers for Enhanced Tumor Therapy

Metal–Organic Framework (MOF)‐Based Ultrasound‐Responsive Dual‐Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy

A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies

Construction of Novel Nanocomposites (Cu-MOF/GOD@HA) for Chemodynamic Therapy

Glucose oxidase-amplified CO generation for synergistic anticancer therapy via manganese carbonyl-caged MOFs

A diselenide MOF-based nanomotor dual-driven by carbon monoxide and near-infrared-II light for multimodal tumor-targeted therapy

A Tumor‐Microenvironment‐Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal‐Enhanced Enzyme Dynamic Therapy

Dddr-06. Enhancing Glioblastoma Treatment With Molybdenum Disulfide(Mos2) Nanomaterials And Ultrasound-Triggered Tumor Growth Inhibition

Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem